Esophagitis Treatments
Find Esophagitis Treatments
Brand Name
Dexilant
Generic Name
Dexlansoprazole
View Brand Information FDA approval date: April 12, 2010
Classification: Proton Pump Inhibitor
Form: Capsule
What is Dexilant (Dexlansoprazole)?
DEXILANT is a proton pump inhibitor indicated in patients 12 years of age and older for: Healing of all grades of erosive esophagitis .
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
Evaluating the Effectiveness of Anti- Ulcerants (Dexlansoprazole, Lansoprazole, and Vonoprazan) With Levofloxacin-based Triple Therapy for Helicobacter Pylori Eradication - A Three-arm Randomized Controlled Trial
Summary: This study, titled CURE-H. Pylori, is a three-arm, parallel-group, open-label, randomized controlled trial designed to evaluate the effectiveness of Dexlansoprazole, Lansoprazole, and Vonoprazan in combination with Levofloxacin and Amoxicillin for Helicobacter pylori eradication. H. pylori infection is a significant health issue worldwide, with an estimated prevalence of 44% globally and around 60...